Find the triggers behind your symptoms
Mymee is the first digital care solution proven to help autoimmune patients reduce rheumatic flares associated with:
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Lupus
- Mixed connective tissue disorder
- IBD, Psoriasis, MS and long COVID with rheumatic symptoms


Industry Partners & Recognition













Clinically Validated

Clinically Validated
Mymee’s proprietary method of identifying an individual’s unique autoimmune disease & long COVID triggers has been validated in real world studies & peer-reviewed publications, demonstrating statistically significant improvements in joint pain, fatigue, stiffness, brain fog, muscle weakness, & other rheumatic symptoms:
- >40% mean reduction in 59 moderate to high-frequency symptoms
- >70% of patients reversed HRQoL severity level from moderate-to-severe to mild-to-normal (as measured by PROMISⓇ)
Mymee is HIPAA- and SOC-2 compliant, and adheres to strict privacy standards to protect data.
Industry leaders support Mymee

"Mymee is a completely new treatment modality for autoimmune disease and as a clinician, that is fascinating. It is a great alternative in a field that has not evolved very much despite pharmacological advancements."
Kurt Herzer, MD, PhD, Former Head of Population Health, Oscar Health

"As part of our trusted performance network, Mymee has been a true innovation partner in working with our post COVID Recovery clinic to manage the care of as many people with long COVID as possible."
Dr. David Putrino, Director of Rehabilitation Innovation at Mount Sinai Hospital

"As an innovator in the healthcare industry, I know an effective product when see it. And as someone whose family member directly benefited from the Mymee program, I can attest to the fact that Mymee works."
John Bell, VP External Innovation & New Business Models, Johnson & Johnson
Why Mymee?
Autoimmune diseases share the common thread of the immune system attacking cells in reaction to variables that comprise the exposome. The exposome encompasses all exposures of an individual in a lifetime and how those exposures relate to health.
When a primary medication (Rx) does not protect against these reactions, additional Rx, supplements and diets are recommended. While trial & error works for some, others face reduced Rx efficacy and more frequent and severe symptoms.
Mymee solves the "trial & error" challenge through a personalized trial and care process that identifies complex interactions between exposome variables and helps patients correlate symptoms and triggers to significantly improve health in an average 17 weeks.
The Exposome
The solution includes a custom mobile app, proprietary data platform and weekly analysis sessions with a specialized health coach. Rx tapering support is based on genetics, personal preferences and health needs, in accordance with physician and pharmacist recommended drug regimen.
Patient testimonials
Trusted by patients
.png)
Get help today with Mymee
